As of 2025-05-17, the Intrinsic Value of Oragenics Inc (OGEN) is -2.46 USD. This OGEN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.20 USD, the upside of Oragenics Inc is -1,329.97%.
Based on its market price of 0.20 USD and our intrinsic valuation, Oragenics Inc (OGEN) is overvalued by 1,329.97%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.46 - -2.46 | -2.46 | -1,329.97% |
| P/E | (0.16) - (8.35) | (0.20) | -198.4% |
| DDM - Stable | (4.19) - (15.14) | (9.67) | -4933.1% |
| DDM - Multi | (3.63) - (10.59) | (5.46) | -2827.8% |
| Market Cap (mil) | 4.30 |
| Beta | 2.20 |
| Outstanding shares (mil) | 21.48 |
| Enterprise Value (mil) | 3.76 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.57% |
| Cost of Debt | 5.00% |
| WACC | 9.15% |